Nevirapine
- Product NDC
- 51991-331
- 11-digit product format
- 519910331
- Labeler code
- 51991
- Product ID
- 51991-331_5c7e2529-a647-4ce1-a793-b003df0841a9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- NEVIRAPINE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Breckenridge Pharmaceutical, Inc.
- Application
- ANDA078644
- Marketing category
- ANDA
- Marketing start
- 2011-04-11
- Marketing end
- 2021-05-31
- Substance
- NEVIRAPINE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [EXT],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51991-331-06 | 51991033106 | 60 TABLET in 1 BOTTLE (51991-331-06) | 60 tablet | 2011-04-11 | 2021-05-31 | No | No | Current |